Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
09/2012
09/19/2012EP2500344A1 Aminothiazine or aminooxazine derivative having amino linker
09/19/2012EP2499136A1 3-(3,4-dihydro-2h-benzo [1,4]oxazin-6-yl)-1h-pyrimidin-2,4-dione compounds as herbicides
09/19/2012EP2499124A1 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof
09/19/2012EP2499121A1 Oxazoline derivatives for treatment of cns disorders.
09/19/2012EP2498608A1 Benzene sulfonamide thiazole and oxazole compounds
09/19/2012CN102686590A Pyrazoline dione derivatives as NADPH oxidase inhibitors
09/19/2012CN102686584A Aminothiazine or aminooxazine derivative having amino linker
09/19/2012CN102686583A Herbicidal tetrahydrophthalimides
09/19/2012CN102686581A Novel quinazoline derivatives
09/19/2012CN102686580A Imidazole derivative as casein kinase inhibitors
09/19/2012CN102686579A Compounds and compositions as modulators of GPR119 activity
09/19/2012CN102686578A Bicyclic heteroaryl inhibitors of PDE4
09/19/2012CN102686572A Oxazoline derivatives for treatment of CNS disorders
09/19/2012CN102686571A Tricyclic heterocyclic compounds
09/19/2012CN102686569A Phenoxy-substituted pyrimidines as opioid receptor modulators
09/19/2012CN102686564A 吡咯烷衍生物 Pyrrolidine derivative
09/19/2012CN102686563A Substituted benzamide derivatives
09/19/2012CN102675304A Cyanine compound, optical recording material using the same and optical recording medium
09/19/2012CN102675301A Synthesis of 5-{1-[-methyl-5-(2H-[1,2,3]triazolyl)-1H-indazolyl]-ethyl}-benzooxazolyl-2-amino compounds
09/19/2012CN102675300A Lipoic acid-aporphine conjugated compound, medicine composite and usage thereof
09/19/2012CN102675240A 4-substitute-2-hydroxy morpholine-3-one and preparation method thereof
09/19/2012CN102675224A 2-substituent-7-fluorine-4-aromatic mixed base quinazoline derivant and preparation method and use thereof
09/19/2012CN101835764B Azolecarboxamide compound or salt thereof
09/19/2012CN101528740B Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists
09/19/2012CN101374828B Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
09/18/2012US8268996 Compounds and compositions as cathepsin S inhibitors
09/18/2012US8268994 Fused ring heterocycle kinase modulators
09/18/2012US8268873 Inhibitors of IMPDH enzyme
09/18/2012US8268852 Heterocyclic inhibitors of MEK and methods of use thereof
09/18/2012US8268833 Inhibitors of histone deacetylase
09/18/2012US8268818 Inhibitors of C-MET and uses thereof
09/18/2012US8268815 Pyrimidine compounds and use thereof
09/18/2012US8268809 Kinase inhibitors for preventing or treating pathogen infection and method of use thereof
09/18/2012CA2607907C Method for producing indole derivative having piperidine ring
09/18/2012CA2521069C Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
09/18/2012CA2273083C Synthesis of epothilones, intermediates thereto, analogues and uses thereof
09/13/2012WO2012122388A2 Chip-last embedded interconnect structures and methods of making the same
09/13/2012WO2012122171A1 Herbicidal bis-nitrogen-containing oxo heterocycles
09/13/2012WO2012121992A1 Mst1 kinase inhibitors and methods of their use
09/13/2012WO2012121919A2 Selective ligands for the dopamine 3 (d3) receptor and methods of using the same
09/13/2012WO2012121424A1 Novel oxazolidinone derivative having cyclic amidrazone group and pharmaceutical composition containing same
09/13/2012WO2012121314A1 Dipyridylamine derivative
09/13/2012WO2012120428A1 Novel kinase inhibitors
09/13/2012WO2012120397A1 Fluoro-pyridinone derivatives useful as antibacterial agents
09/13/2012WO2012120195A1 New pyridazinone and pyridone compounds
09/13/2012WO2012120141A1 Π (pi)-conjugated fluoroionophores and method for determining an alkali ion
09/13/2012WO2012120135A1 Isoxazole derivatives
09/13/2012WO2012119978A1 Quinolinone derivatives
09/13/2012WO2012090043A8 Novel solid state forms of azilsartan medoxomil and preparation thereof
09/13/2012WO2012087182A3 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
09/13/2012WO2012074437A3 Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for the production and use thereof
09/13/2012WO2012072791A3 2-(1-phenyl-4,5,6,7-tetrahydro-1h-indazol-4-yl)ethylamine derivatives useful as sigma receptor inhibitors
09/13/2012US20120232277 Process for the preparation of 1,2,4-oxadiazol-3-yl derivatives of carboxylic acid
09/13/2012US20120232265 1,2-Disubstituted Heterocyclic Compounds
09/13/2012US20120232116 Novel fxr (nr1h4) binding and activity modulating compounds
09/13/2012US20120232104 Novel sulfonamides as l-cpt1 inhibitors
09/13/2012US20120232079 Novel acylpiperazinones and their use as pharmaceuticals
09/13/2012US20120232071 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/13/2012US20120232070 Use of Indole Derivatives as Nurr-1 Activators for the Application Thereof as a Medicament for the Treatment of Parkinson's Disease
09/13/2012US20120232068 Quinazolines as potassium ion channel inhibitors
09/13/2012US20120232063 2-Aminoindole Compounds And Methods For The Treatment Of Malaria
09/13/2012US20120232056 Heterocyclic compounds for the inhibition of pask
09/13/2012US20120232052 Aryl carboxamide derivatives as ttx-s blockers
09/13/2012US20120232051 3-amino-pyridines as gpbar1 agonists
09/13/2012US20120232050 Cyclic Inhibitors of 11 beta-Hydroxysteroid Dehydrogenase 1
09/13/2012US20120232049 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene
09/13/2012US20120232033 Amines or amino alcohols as glyt1 inhibitors
09/13/2012US20120231952 3-(3,4-dihydro-2H-benzo [1,4]oxazin-6-yl)-1H-Pyrimidin-2,4-dione compounds as herbicides
09/13/2012US20120231392 Salt, resist composition and method for producing resist pattern
09/13/2012US20120231017 Heterocyclic aspartyl protease inhibitors
09/13/2012CA2832377A1 New pyridazinone and pyridone compounds
09/13/2012CA2830706A1 Quinolinone derivatives
09/13/2012CA2829187A1 Dipyridylamine derivative
09/13/2012CA2829149A1 Isoxazole derivatives
09/13/2012CA2828578A1 Mst1 kinase inhibitors and methods of their use
09/13/2012CA2828337A1 Fluoro-pyridinone derivatives useful as antibacterial agents
09/12/2012EP2496704A1 Therapeutic compounds
09/12/2012EP2496573A1 Herbicidal tetrahydrophthalimides
09/12/2012EP2496557A1 Tetrahydroquinoline derivatives and their pharmaceutical use
09/12/2012CN102666532A Pyrazole derivatives
09/12/2012CN102666531A Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
09/12/2012CN102666525A Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof
09/12/2012CN102666508A Phenyloxadiazole derivatives as pgds inhibitors
09/12/2012CN102666507A Oxazine derivatives and their use in the treatment of neurological disorders
09/12/2012CN102666506A Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of dpp-1
09/12/2012CN102666500A Seven-membered ring compound and pharmaceutical use therefor
09/12/2012CN102666498A RAF inhibitor compounds and methods of use thereof
09/12/2012CN102659774A Piperidine and piperazine derivatives as P2X3 antagonists
09/12/2012CN102659773A Green-light iridium (III) coordination compounds containing oxadiazole base groups as well as preparation method and application thereof
09/12/2012CN102659772A 2-aryl benzo heterocyclic compound with affinity with A beta plaques, and preparation method and application thereof
09/12/2012CN102659771A Novel lloperidone pharmaceutical co-crystal and preparation method thereof
09/12/2012CN102659764A Tyrosine kinase inreversible inhibitor, its preparation method and application
09/12/2012CN102659705A Synthetic method of 3,4-disubstituted isoxazole compound
09/11/2012US8263782 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors
09/11/2012US8263781 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
09/11/2012US8263657 Blocking neurokinins; using a benzene compound containing hydroxy or acetoxy group; antiinflammatory agents
09/11/2012US8263630 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type I inhibitors
09/11/2012US8263624 Aryl-substituted heterocycles, and use thereof
09/11/2012US8263620 Oxadiazole derivatives active on sphingosine-1-phosphate (SIP)
09/11/2012US8263597 Indazole compounds as CCR1 receptor antagonists
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 647